PHASE-I CONTROLLED TRIALS OF WR-2721 AND CYCLOPHOSPHAMIDE

被引：42

作者：

GLICK, JH

GLOVER, D

WEILER, C

NORFLEET, L

YUHAS, J

KLIGERMAN, MM

机构：

[1] UNIV PENN,CTR CANC,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104

[2] UNIV PENN,CTR CANC,DEPT RADIOTHERAPY,PHILADELPHIA,PA 19104

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1984年 / 10卷 / 09期

关键词：

D O I：

10.1016/0360-3016(84)90548-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1777 / 1780

页数：4

共 10 条

[1]

BERGSAGEL DE, 1968, CAN MED ASSOC J, V98, P532

[2] PHASE-I CLINICAL-TRIALS OF WR-2721 WITH ALKYLATING AGENT CHEMOTHERAPY [J].

GLICK, JH ;

GLOVER, DJ ;

WEILER, C ;

BLUMBERG, A ;

NELSON, D ;

YUHAS, JM ;

KLIGERMAN, M .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4) :575-580

[3]

GLICK JH, 1983, 1ST P C RAD ANT, P719

[4]

KLIGERMAN MM, 1981, CANCER CLIN TRIALS, V4, P469

[5]

PHILLIPS TL, 1981, SEMIN ONCOL, V8, P65

[6]

WASSERMAN TH, 1981, CANCER CLIN TRIALS, V4, P3

[7] CLINICAL-TRIAL OF THE EFFECT OF S-2-(3-AMINOPROPYLAMINO)-ETHYLPHOSPHOROTHIOIC ACID (WR-2721) (NSC-296961) ON THE TOXICITY OF CYCLOPHOSPHAMIDE [J].

WOOLLEY, PV ;

AYOOB, MJ ;

SMITH, FP ;

DRITSCHILO, A .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (03) :198-203

[8] TREATMENT OF TUMORS WITH THE COMBINATION OF WR-2721 AND CIS-DICHLORODIAMMINEPLATINUM (II) OR CYCLOPHOSPHAMIDE [J].

YUHAS, JM ;

SPELLMAN, JM ;

JORDAN, SW ;

PARDINI, MC ;

AFZAL, SMJ ;

CULO, F .

BRITISH JOURNAL OF CANCER, 1980, 42 (04) :574-585

[9]

YUHAS JM, 1979, CANCER TREAT REP, V63, P971

[10]

Yuhas JMS, 1980, RAD SENSITIZERS, P303

← 1 →